Sumitomo Pharma America, Inc
This role involves planning and tracking statistical programming activities, including designing, developing, and validating SAS programs to generate analysis datasets and supporting safety and efficacy analyses for clinical studies. The position requires collaborating with biostatisticians and clinical teams to create study-specific data listings, summary tables, and regulatory submission files while championing programming best practices across the department.
Headquarters
Marlborough, Massachusetts, United States
Company Size
1001-5000 employees
Founded
2023
N/A
Sumitomo Pharma America Announces that the European Medicines Agency Has Granted Orphan Drug Designation to Nuvisertib (TP-3654) for the Treatment of Myelofibrosis
Jul 30, 2025
Knight Therapeutics and Sumitomo Pharma enter into
Jun 5, 2025
Sumitomo Pharma’s Comeback Story: Reinventing a Century-Old Giant in a Post-Patent Era
Apr 22, 2025
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Sumitomo Pharma America, Inc.
19% above the average for this role
Sumitomo Pharma America and Former Professional Quarterback Rodney Peete Say it's Time to Go™ and Put Yourself First with Overactive Bladder Treatment Option GEMTESA®
Jun 30, 2025